comparemela.com

Page 8 - Heron Therapeutics Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Heron Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results On Tuesday, March 12, 2024

/PRNewswire/ Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company, today announced that the company will host a conference call.

Antiemetic Drug Market size is to grow by USD 1 63 billion, The increasing healthcare expenditure to boost market growth, Technavio

vimarsana © 2020. All Rights Reserved.